Today, the Centers for Medicare & Medicaid Services (CMS) released guidance to build on SAE’s commitment to partner with states to ensure they have the necessary regulatory tools and flexibility to combat the opioid crisis. Their two releases also describe the approaches states can use to address this crisis, ensure awareness of available resources, and articulate promising practices for addressing the needs of beneficiaries facing opioid addiction.
CMS issued a letter to states on how they may best use federal funding to enhance Medicaid technology to combat drug addiction and the opioid crisis. Additionally, CMS posted a new Informational Bulletin that provides states with information they can use when designing approaches to cover critical treatment services for Medicaid-eligible infants with Neonatal Abstinence Syndrome (NAS).
SAE can help with the rapid assessments of need, tailored service developments for a comprehensive continuum of care, and full evaluation for service impact. If you would like to explore how we can help you in this arena, email email@example.com or call us at (212) 684-4480 to connect with our team.
Keep an eye out for SAE’s upcoming release: SAE’s Operational Guide to the Treatment, Prevention, and Evaluation of Opioid Addiction, set to come out this week!